Evidence 1
Activity
Activity
4% Hemolysis
Toxicity
>64 µM
Hemolytic
Cytotoxic
4% Hemolysis | >64 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Lentivirus-derived antimicrobial peptides: increased potency by sequence engineering and dimerization. | J Antimicrob Chemother | 1999